Is the price fair?
What RDY's price assumes
Dr. Reddy's Laboratories Limited did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 0.01× revenue.
0.01
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.03
Price / book · as of 2025-FY
- EV / sales
- 0.00
EV / sales
Details›
- Price / book2025-FY
- 0.03
- EV / EBIT2025-FY
- 0.02
- EV / sales2025-FY
- 0.00
- Market capitalisation
- $11.1B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers - Specialty & Generic
Ranks #24 of 28 by Smart Score